GlassScriptPhysician profile
Hetal R Bhakta
NPI 1336248285
$17,875.93
in general payments reported to CMS, 2019-2025
31 companies · $4,189 in 2025
The $4,189 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,352 · 2020: $1,765 · 2021: $2,487 · 2022: $2,222 · 2023: $3,328 · 2024: $2,534 · 2025: $4,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,652 · Travel and Lodging: $2,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,651.85 |
| Travel and Lodging | $2,398.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,872.02 | 2019-2025 | Farapulse, Watchman Flx, Versacross Access Solution |
| Medtronic, INC. | $4,100.47 | 2021-2025 | Linq II, Reveal Linq, Micra |
| Abbott Laboratories | $1,900.47 | 2019-2025 | Aveir, Perclose Proglide, Mitraclip |
| Medtronic Vascular, INC. | $1,628.14 | 2019-2020 | |
| Biosense Webster, INC. | $618.32 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Nuvision Ice Catheter |
| Atricure, INC. | $602.86 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Janssen Pharmaceuticals, INC | $326.95 | 2019-2023 | Xarelto |
| Impulse Dynamics (USA) INC. | $223.18 | 2023-2024 | Optimizer, Optimizer |
| E.R. Squibb & Sons, L.L.C. | $177.46 | 2019-2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $173.50 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $170.41 | 2019-2024 | Lifevest |
| Biotronik INC. | $145.21 | 2021-2023 | Biomonitor, Acticor 7 Vr-T Dx |
| Lexicon Pharmaceuticals, INC. | $115.83 | 2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $113.20 | 2022 | |
| Cardiva Medical, INC. | $80.79 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $78.68 | 2024-2025 | Remede System |
| Merck Sharp & Dohme LLC | $60.79 | 2023-2025 | Verquvo |
| Cvrx, INC. | $60.35 | 2025 | Barostim Neo System |
| Irhythm Technologies, INC. | $60.23 | 2021-2023 | Zio Xt Patch |
| Kiniksa Pharmaceuticals International, Plc | $56.94 | 2024 | Arcalyst |
| Medicomp INC | $55.34 | 2023 | Telepatch Cardiac Monitor |
| Baxter Healthcare | $48.14 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.69 | 2020 | |
| Amgen INC. | $26.79 | 2022 | |
| Imperative Care, INC | $26.42 | 2025 | Zoom Reperfusion Catheter |
| Abiomed | $24.49 | 2019 | |
| Acutus Medical, INC. | $22.96 | 2020 | |
| Stereotaxis INC | $22.46 | 2022 | |
| Cordis US Corp. | $21.85 | 2025 | Mynx Control Venous |
| Astrazeneca Pharmaceuticals LP | $18.36 | 2019 | |
| Pfizer INC. | $15.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hetal Bhakta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.